Skip to main content
EJNMMI Physics

Table 6 Relative contribution of 223Ra and its progeny to the total absorbed dose of endosteum, red marrow, liver and kidneys (in %)

From: Radiopharmacokinetic modelling and radiation dose assessment of 223Ra used for treatment of metastatic castration-resistant prostate cancer

 

223Ra

219Rn

215Po

211Pb

211Bi

211Po

207TI

Tissue

       

Red marrow

19

24

26

4

22

0

4

Endost-BS

21

25

27

1

24

0

1

Liver

21

24

27

2

24

0

2

Kidneys

20

24

26

2

26

0

2

  1. Endost-BS, endosteum (endosteal cells)
Back to article page